2012 Fiscal Year Final Research Report
Study on the mechanism of anti-angiogenesis and tumorigenesis through genomic function of nuclear receptor
Project/Area Number |
23790075
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Biological pharmacy
|
Research Institution | University of Tsukuba |
Principal Investigator |
NAKAJIMA Yuka 筑波大学, 生命環境系, 助教 (40399499)
|
Project Period (FY) |
2011 – 2012
|
Keywords | 血管新生 / 腫瘍形成 / エストロゲン受容体 |
Research Abstract |
I found that ER ligands suppress tumor angiogenesis of androgen independent prostate cancer through novel non-genomic pathway of ERβ, and thereby inhibit tumor growth. Moreover, I also found that NFκB is novel target gene of ERβ non-genomic pathway, and identified some inhibitory compounds of NFκB activity. These findings may provide a suitable target for androgen independent prostate cancer treatment.
|
Research Products
(10 results)